Furthermore, the results from bilateral mouse CT26 model experiment showed that rPR8-CCL19 significantly inhibited tumor growth after different treatment for tumors (Figure 6C) and improved mouse survival significantly (Figure 6D). The gene discussed is CCL19; the disease is neoplasm.